m+Medelevator.RU
← Поиск публикаций
Respiratory medicine · 2026

Predicting mortality risk in pediatric severe pneumonia using a CNN-BiLSTM model with dynamic clinical indicators.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Qi Wanqing, Ding Chaoying, Tu Hongdi, Yang Luying, Cao Liangshen, Yan Chaoyang, Chen Zhengrong, Sun Hongpeng

Аннотация

BACKGROUND: Severe pneumonia is a leading cause of mortality in children under 5 years old, and there is currently a lack of reliable biomarkers for early warning of adverse outcomes in the ICU. This study aimed to explore effective prognostic biomarkers for severe pneumonia and apply a deep learning model to predict in-hospital mortality in children with severe pneumonia, thereby supporting clinical decision-making.

METHODS: This retrospective prognostic study analyzed clinical data from children under 5 years of age with severe pneumonia from the Pediatric Intensive Care (PIC) database. Patients were categorized according to in-hospital mortality status. Dynamic biomarker screening was performed from longitudinal laboratory data, and a CNN-BiLSTM-based prediction model was subsequently constructed using the selected biomarkers.

RESULTS: Eleven key predictive indicators were identified from the laboratory parameters. The CNN-BiLSTM model achieved an area under the curve (AUC) of 0.956 on an independent test set, with a sensitivity of 85.7% and a specificity of 92.7%. Interpretability analysis revealed that lactate, partial pressure of carbon dioxide (pCO2), and pH were the most influential predictors.

CONCLUSION: This study provides an effective tool for dynamic risk stratification in children with severe pneumonia, offering support for timely clinical decision-making in the ICU. Future multi-center studies are still needed to validate the effectiveness of this model.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты